傅永伦 - 同济大学

个人简介

从事辅助生殖相关临床工作20余年，临床经验丰富，科研功底扎实，勇于在实践中探索新方法，提出了诸多革新性理念。2012年创造性的将天然孕激素用于卵巢刺激过程中，设计出世界首例基于冷冻胚胎移植的孕激素方案——“安琪坦方案”，目前孕激素方案已得到国内外同行的广泛认可及应用，2019年欧洲人类生殖与胚胎学学会（European Society of Human Reproduction and Embryology, ESHRE）将孕激素方案写入最新版的卵巢刺激指南；在此基础上，进一步研究设计出“晚卵泡期卵巢刺激方案”，该方案自晚卵泡期启动，单用Gn完成卵巢刺激，无需额外添加外源性垂体调控剂。目前以第一作者或者通讯作者发表SCI文章13篇，主持课题4项，担任多个SCI期刊审稿人：Frontiers in endocrinology，American journal of reproductive immunology，Gynecological Endocrinology，Medicine，Scientific reports，Human fertility，Journal of Obstetrics and Gynaecology等。

研究领域

生殖医学生殖内分泌学卵巢刺激方案个体化应用研究

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Xiuxian Zhu, Jing Ye, Yonglun Fu*. Premature ovarian insufficiency patients with viable embryos derived from autologous oocytes through repeated oocyte retrievals could obtain reasonable cumulative pregnancy outcomes following frozen-embryo transfer. Ann Transl Med, 2021,9(7):539. (IF=3.932) Xiuxian Zhu, Jing Ye, Yonglun Fu*. Progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in women with polycystic ovarian syndrome undergoing in vitro fertilization treatments with frozen-thawed embryo transfer: a prospective randomized controlled trial. Ann Transl Med, 2021,9(5):387.(IF=3.932) Xiuxian Zhu, Jing Ye, Yonglun Fu*. Late follicular phase ovarian stimulation without exogenous pituitary modulators, Front Endocrinol (Lausanne), 2020,11:487. (IF=5.555) Xiuxian Zhu, Yonglun Fu*. Randomized, controlled pilot study of low-dose human chorionic gonadotropin administration beginning from the early follicular phase for women with polycystic ovarian syndrome undergoing ovarian stimulation using the progesterone protocol. Front Endocrinol (Lausanne), 2019,10:875. (IF=3.644) Xiuxian Zhu, Yonglun Fu*. Evaluation of ovarian stimulation initiated from the late follicular phase using human menopausal gonadotropin alone in normal-ovulatory women for treatment of infertility: a retrospective cohort study, Front Endocrinol (Lausanne), 2019,10:448. (IF=3.644) Ningling Wang, Jiaying Lin, Qianqian Zhu , Yong Fan, Yun Wang, Yonglun Fu*, Yanping Kuang*.Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: a large retrospective cohort study. Medicine (Baltimore),2018,97(34):e11906. (IF=1.87) Xiuxian Zhu, Hongjuan Ye, Yonglun Fu*. Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation. Fertil Steril, 2017,108(3): 505~512. (IF=4.803) Xiuxian Zhu, Hongjuan Ye, Yonglun Fu*. Use of Utrogestan duringcontrolled ovarian hyperstimulation in normally ovulating women undergoing invitro fertilization or intracytoplasmic sperm injection treatments incombination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg. Fertil Steril, 2017, 107(2): 379~386. (IF=4.803) Xiuxian Zhu, Hongjuan Ye, Yonglun Fu*. The effect of frozen-thawed embryo transfer performed concurrently with hysteroscopy on the reproductive outcomes during assisted reproductive treatments. Sci Rep, 2017, 7(1): 11852. (IF=4.122) Xiuxian Zhu, Hongjuan Ye, Yonglun Fu*. Comparison of neonatal outcomes following progesterone use during ovarian stimulation with frozen-thawed embryo transfer. Sci Rep, 2017, 7(1): 7835. (IF=4.122) Xiuxian Zhu, Hongjuan Ye, Yonglun Fu*. The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments. Medicine (Baltimore), 2016, 95(28): e4193. (IF=1.803) Xiuxian Zhu, Xiaole Zhang, Yonglun Fu*. Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Medicine (Baltimore), 2015, 94(21): e909. (IF=1.206) Yun Wang#, Yonglun Fu#, Songguo Xue, Ai Ai, Hong Chen, Qifeng Lyu, Yanping Kuang*. The M2 polarization of macrophage induced by fractalkine in the endometriotic milieu enhances invasiveness of endometrial stromal cells. Int J Clin Exp Pathol. 2013 Dec 15;7(1):194-203. (IF=1.783)